0.4400
-0.0100
(-2.22%)
At close: 4:00:01 PM EST
0.4580
+0.02
+(4.09%)
After hours: 6:03:30 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.09 | -0.08 | -0.54 | -0.3 |
| Low Estimate | -0.09 | -0.08 | -0.54 | -0.3 |
| High Estimate | -0.09 | -0.08 | -0.54 | -0.3 |
| Year Ago EPS | -0.25 | -0.21 | -- | -0.54 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 3 | 2 | 3 |
| Avg. Estimate | 15.31M | 17.13M | 57.02M | 90.92M |
| Low Estimate | 14.87M | 13.5M | 56.6M | 59.48M |
| High Estimate | 15.75M | 23.9M | 57.44M | 131.55M |
| Year Ago Sales | 13.46M | 10.88M | 46.74M | 57.02M |
| Sales Growth (year/est) | 13.72% | 57.42% | 21.99% | 59.46% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.21 | -0.1 | -0.14 | -0.1 |
| EPS Actual | -0.25 | -0.21 | -0.26 | -0.04 |
| Difference | -0.04 | -0.11 | -0.12 | 0.06 |
| Surprise % | -19.05% | -110.00% | -87.11% | 61.00% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.09 | -0.08 | -0.54 | -0.3 |
| 7 Days Ago | -0.1 | -0.12 | -0.5 | -0.4 |
| 30 Days Ago | -0.1 | -0.12 | -0.5 | -0.4 |
| 60 Days Ago | -0.1 | -0.12 | -0.5 | -0.4 |
| 90 Days Ago | -0.1 | -0.12 | -0.5 | -0.4 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | -- | -- | 1 |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SCLX | 64.00% | 61.90% | -- | 44.44% |
| S&P 500 | 9.01% | 10.57% | 14.00% | 13.70% |
Upgrades & Downgrades
| Initiated | D. Boral Capital: Buy | 1/27/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/21/2024 |
| Initiated | Alliance Global Partners: Buy | 10/16/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/17/2024 |
| Initiated | Rodman & Renshaw: Buy | 6/13/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/11/2024 |
Related Tickers
AMRN Amarin Corporation plc
0.5816
+2.94%
MIRA MIRA Pharmaceuticals, Inc.
1.2600
+10.53%
SNY Sanofi
54.15
+3.84%
AZN AstraZeneca PLC
71.24
+1.41%
GILD Gilead Sciences, Inc.
96.95
+1.42%
BIIB Biogen Inc.
146.23
+1.26%
GSK GSK plc
35.36
+0.86%
BAYRY Bayer Aktiengesellschaft
5.70
+0.71%
RHHBY Roche Holding AG
39.85
+2.55%
PFE Pfizer Inc.
26.91
+1.09%